Literature DB >> 17438040

Identification of a Campylobacter jejuni protein that cross-reacts with cholera toxin.

M John Albert1, Shilpa Haridas, David Steer, Gursev S Dhaunsi, A Ian Smith, Ben Adler.   

Abstract

The question of whether Campylobacter jejuni produces a cholera toxin-like toxin (CTLT) has been controversial. The objective of this study was to identify the factor that cross-reacts with CT from C. jejuni. Filtrates of C. jejuni grown in four different liquid media reported to promote CTLT production were tested by Chinese hamster ovary (CHO) cell elongation assay and for reactivity with CT antibody using GM1 ganglioside enzyme-linked immunosorbent assay (ELISA) and immunoblotting. Protein sequence was determined by matrix-assisted laser desorption ionization-time of flight (MALDI TOF-TOF). Filtrates from seven reference strains reported to produce CTLT and from 80 clinical strains were negative in the CHO cell assay, but those from three reference strains and 16 clinical strains were positive by GM1 ELISA. All strains tested, including C. jejuni NCTC 11168, which does not contain a CT gene homologue, possessed a 53-kDa protein which reacted with CT antibody by immunoblotting. This band was identified as the major outer membrane protein, PorA, of C. jejuni. CT antibody reacted by immunoblotting with a recombinant PorA, but antibody to the recombinant PorA did not react with CT. Our results indicate that C. jejuni does not produce a functional CTLT, but the reactivity of PorA with CT antibody would lead to the erroneous conclusion that C. jejuni produces a functional CTLT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17438040      PMCID: PMC1932847          DOI: 10.1128/IAI.00139-07

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Toxin production by Campylobacter spp.

Authors:  T M Wassenaar
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences.

Authors:  J Parkhill; B W Wren; K Mungall; J M Ketley; C Churcher; D Basham; T Chillingworth; R M Davies; T Feltwell; S Holroyd; K Jagels; A V Karlyshev; S Moule; M J Pallen; C W Penn; M A Quail; M A Rajandream; K M Rutherford; A H van Vliet; S Whitehead; B G Barrell
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The economic burden of Campylobacter-associated Guillain-Barré syndrome.

Authors:  J C Buzby; B M Allos; T Roberts
Journal:  J Infect Dis       Date:  1997-12       Impact factor: 5.226

5.  PorA protein of Campylobacter jejuni is not a cytotoxin mediating inflammatory diarrhoea.

Authors:  Islam Khan; Ben Adler; Shilpa Haridas; M John Albert
Journal:  Microbes Infect       Date:  2005-04-14       Impact factor: 2.700

6.  The serological relationship between Yersinia enterocolitica O9 and Escherichia coli O157 using sera from patients with yersiniosis and haemolytic uraemic syndrome.

Authors:  H Chart; T Cheasty; D Cope; R J Gross; B Rowe
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

7.  Clinical and immunologic significance of cholera-like toxin and cytotoxin production by Campylobacter species in patients with acute inflammatory diarrhea in the USA.

Authors:  G I Perez-Perez; D L Cohn; R L Guerrant; C M Patton; L B Reller; M J Blaser
Journal:  J Infect Dis       Date:  1989-09       Impact factor: 5.226

8.  Profiles of toxin production by thermophilic Campylobacter of animal origin.

Authors:  B A McFarland; S D Neill
Journal:  Vet Microbiol       Date:  1992-02       Impact factor: 3.293

9.  Enzyme-linked immunosorbent assays for virulence properties of Campylobacter jejuni clinical isolates.

Authors:  F A Klipstein; R F Engert; H B Short
Journal:  J Clin Microbiol       Date:  1986-06       Impact factor: 5.948

Review 10.  Campylobacter species and Guillain-Barré syndrome.

Authors:  I Nachamkin; B M Allos; T Ho
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

View more
  10 in total

Review 1.  Controlled Human Infection Models To Accelerate Vaccine Development.

Authors:  Robert K M Choy; A Louis Bourgeois; Christian F Ockenhouse; Richard I Walker; Rebecca L Sheets; Jorge Flores
Journal:  Clin Microbiol Rev       Date:  2022-07-06       Impact factor: 50.129

2.  Major outer membrane proteins from many Campylobacter species cross-react with cholera toxin.

Authors:  M John Albert; Shilpa Haridas; Ben Adler
Journal:  Clin Vaccine Immunol       Date:  2008-03-19

3.  Evaluation of procedures for outer membrane isolation from Campylobacter jejuni.

Authors:  Rhonda I Hobb; Joshua A Fields; Christopher M Burns; Stuart A Thompson
Journal:  Microbiology (Reading)       Date:  2009-03       Impact factor: 2.777

4.  Oral immunization with cholera toxin provides protection against Campylobacter jejuni in an adult mouse intestinal colonization model.

Authors:  M John Albert; Abu Salim Mustafa; Anjum Islam; Shilpa Haridas
Journal:  mBio       Date:  2013-05-07       Impact factor: 7.867

Review 5.  Cross-reactivity of outer membrane proteins of Campylobacter species with cholera toxin.

Authors:  M John Albert
Journal:  Indian J Med Res       Date:  2011-02       Impact factor: 2.375

6.  Processed foods drive intestinal barrier permeability and microvascular diseases.

Authors:  Matthew Snelson; Sih Min Tan; Rachel E Clarke; Cassandra de Pasquale; Vicki Thallas-Bonke; Tuong-Vi Nguyen; Sally A Penfold; Brooke E Harcourt; Karly C Sourris; Runa S Lindblom; Mark Ziemann; David Steer; Assam El-Osta; Michael J Davies; Leigh Donnellan; Permal Deo; Nicole J Kellow; Mark E Cooper; Trent M Woodruff; Charles R Mackay; Josephine M Forbes; Melinda T Coughlan
Journal:  Sci Adv       Date:  2021-03-31       Impact factor: 14.136

7.  The AprV5 subtilase is required for the optimal processing of all three extracellular serine proteases from Dichelobacter nodosus.

Authors:  Xiaoyan Han; Ruth M Kennan; David L Steer; A Ian Smith; James C Whisstock; Julian I Rood
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

8.  Application of protein purification methods for the enrichment of a cytotoxin from Campylobacter jejuni.

Authors:  Xenia Gatsos; David L Steer; Thamradeen A Junaid; A Ian Smith; Ben Adler; M John Albert
Journal:  BMC Microbiol       Date:  2012-12-23       Impact factor: 3.605

9.  Immunization with a Double-Mutant (R192G/L211A) of the Heat-Labile Enterotoxin of Escherichia coli Offers Partial Protection against Campylobacter jejuni in an Adult Mouse Intestinal Colonization Model.

Authors:  M John Albert; Shilpa Haridas; Mathew Ebenezer; Raj Raghupathy; Islam Khan
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

Review 10.  Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease.

Authors:  Richard Walker; Robert W Kaminski; Chad Porter; Robert K M Choy; Jessica A White; James M Fleckenstein; Fred Cassels; Louis Bourgeois
Journal:  Microorganisms       Date:  2021-06-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.